Deutsche Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.2M Buy
842,551
+72,849
+9% +$6.68M 0.03% 548
2025
Q4
$69.2M Buy
769,702
+90,027
+13% +$8.54M 0.02% 551
2025
Q3
$66.9M Sell
679,675
-28,524
-4% -$2.83M 0.02% 547
2025
Q2
$64.6M Sell
708,199
-153,952
-18% -$14.9M 0.02% 545
2025
Q1
$97.6M Sell
862,151
-60,252
-7% -$6.45M 0.04% 440
2024
Q4
$97.4M Buy
922,403
+3,170
+0.3% +$340K 0.04% 445
2024
Q3
$99.2M Buy
919,233
+162,513
+21% +$17.7M 0.04% 403
2024
Q2
$82.1M Buy
756,720
+28,315
+4% +$3.34M 0.04% 410
2024
Q1
$96.1M Buy
728,405
+18,083
+3% +$2.26M 0.04% 363
2023
Q4
$86.4M Buy
710,322
+80,895
+13% +$9.03M 0.04% 379
2023
Q3
$70.6M Buy
629,427
+28,496
+5% +$3.62M 0.05% 382
2023
Q2
$87.5M Buy
600,931
+253,074
+73% +$34.4M 0.05% 366
2023
Q1
$44.9M Sell
347,857
-15,666
-4% -$1.97M 0.03% 534
2022
Q4
$46.3M Sell
363,523
-15,306
-4% -$1.78M 0.03% 525
2022
Q3
$39.6M Sell
378,829
-5,226
-1% -$573K 0.02% 567
2022
Q2
$40.3M Sell
384,055
-13,407
-3% -$1.59M 0.02% 575
2022
Q1
$50.8M Sell
397,462
-41,537
-9% -$5.01M 0.02% 569
2021
Q4
$54.1M Buy
438,999
+35,923
+9% +$4.7M 0.02% 566
2021
Q3
$57.3M Sell
403,076
-10,956
-3% -$1.61M 0.03% 553
2021
Q2
$64.6M Buy
414,032
+36,282
+10% +$5.88M 0.03% 515
2021
Q1
$58.7M Sell
377,750
-24,546
-6% -$3.8M 0.03% 526
2020
Q4
$60.2M Buy
402,296
+26,243
+7% +$3.71M 0.04% 445
2020
Q3
$49.7M Sell
376,053
-32,801
-8% -$4.28M 0.03% 445
2020
Q2
$47.4M Buy
408,854
+33,766
+9% +$3.89M 0.04% 441
2020
Q1
$36.8M Sell
375,088
-162,495
-30% -$21.3M 0.03% 452
2019
Q4
$78.1M Buy
537,583
+102,623
+24% +$14.2M 0.05% 365
2019
Q3
$58M Sell
434,960
-311,397
-42% -$40.2M 0.04% 437
2019
Q2
$85.3M Buy
746,357
+273,458
+58% +$32M 0.05% 386
2019
Q1
$58.6M Sell
472,899
-172,178
-27% -$19.6M 0.03% 519
2018
Q4
$65M Buy
645,077
+168,471
+35% +$18.9M 0.05% 422
2018
Q3
$60.8M Sell
476,606
-277,695
-37% -$33M 0.03% 574
2018
Q2
$81.6M Sell
754,301
-155,800
-17% -$17M 0.04% 460
2018
Q1
$96.3M Buy
910,101
+536,803
+144% +$62.3M 0.05% 404
2017
Q4
$43.7M Sell
373,298
-16,684
-4% -$1.89M 0.03% 598
2017
Q3
$44.3M Sell
389,982
-61,720
-14% -$7.12M 0.03% 594
2017
Q2
$56.3M Sell
451,702
-8,598
-2% -$1.02M 0.04% 474
2017
Q1
$54.6M Sell
460,300
-410,785
-47% -$46.6M 0.04% 477
2016
Q4
$87.3M Buy
871,085
+279,931
+47% +$30M 0.07% 321
2016
Q3
$74.6M Sell
591,154
-101,356
-15% -$12.5M 0.05% 387
2016
Q2
$80.9M Sell
692,510
-7,595
-1% -$860K 0.06% 370
2016
Q1
$72.5M Buy
700,105
+52,206
+8% +$5.05M 0.05% 382
2015
Q4
$64.5M Buy
647,899
+142,695
+28% +$14M 0.04% 435
2015
Q3
$46.1M Buy
505,204
+19,785
+4% +$1.98M 0.04% 512
2015
Q2
$51.5M Sell
485,419
-26,007
-5% -$2.88M 0.03% 528
2015
Q1
$58.3M Buy
511,426
+126,583
+33% +$14.4M 0.04% 498
2014
Q4
$42.4M Buy
384,843
+283
+0.1% +$29.8K 0.03% 638
2014
Q3
$37.5M Sell
384,560
-229,958
-37% -$22.6M 0.02% 659
2014
Q2
$62M Sell
614,518
-6,881
-1% -$671K 0.04% 460
2014
Q1
$57.1M Buy
621,399
+112,644
+22% +$10.4M 0.04% 478
2013
Q4
$46M Sell
508,755
-123,778
-20% -$10.7M 0.03% 523
2013
Q3
$50.4M Sell
632,533
-193,204
-23% -$15.2M 0.04% 494
2013
Q2
$60.1M Buy
+825,737
New +$61.7M 0.05% 400

Other funds holding ZBH

Deutsche Bank's ZBH Position: Q1 2026 in Review

Deutsche Bank increased its Zimmer Biomet (ZBH) stake by 9.5% in Q1 2026, buying an estimated $6.68M and bringing the position to 842,551 shares worth $76.2M. The position accounts for 0.03% of the portfolio, ranked #548.

Deutsche Bank first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $99.2M in Q3 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Deutsche Bank held 842,551 shares of Zimmer Biomet worth $76.2M as of Q1 2026.
  • Deutsche Bank bought 72,849 Zimmer Biomet shares in Q1 2026, an estimated $6.68M.
  • Zimmer Biomet made up 0.03% of Deutsche Bank's portfolio in Q1 2026, its #548 holding.
  • Deutsche Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Zimmer Biomet position peaked at $99.2M in Q3 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.